Capvizr
THE DEAL, AT A GLANCE

Countable Labs

From the announcement
01What it doesCountable Labs is a helping to democratize access to genomic diagnostics, and high-volume genome-based LegalTech company focused on Accelerate Clinical Product…From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Who is involvedBacked by ARCH Venture Partners, F-Prime Capital, Primer Ventures, Christopher CitraroFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
03What happenedCountable Labs raised $26M Unknown, announced 2026-05-28From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
04Why it mattersCountable Labs is using new financing to accelerate clinical product development and global commercialization of Countable PCR.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Countable Labs · Financing Record

Explore source-linked visual explanations for Countable Labs. Unsupported claims are withheld while source review continues.

Record 4989 · Recorded date: 2026-05-28

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime